2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Jose Luis Zamorano , Patrizio Lancellotti (1) , Daniel Rodriguez Munoz , Victor Aboyans (2) , Riccardo Asteggiano , Maurizio Galderisi (3) , Gilbert Habib (4) , Daniel J. Lenihan , Gregory Y. H. Lip , Alexander R. Lyon , Teresa Lopez Fernandez , Dania Mohty (2) , Massimo F Piepoli , Juan Tamargo , Adam Torbicki , Thomas M. Suter

1 CHU-Liège - Centre Hospitalier Universitaire de Liège
2 NET - Neuroépidémiologie Tropicale
3 University of Naples Federico II = Università degli studi di Napoli Federico II
4 URMITE - Unité de Recherche sur les Maladies Infectieuses Tropicales Emergentes

Domains: Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Surgery

Jose Luis Zamorano, Patrizio Lancellotti, Daniel Rodriguez Munoz, Victor Aboyans, Riccardo Asteggiano, et al.. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). . European Journal of Heart Failure, 2017, 19 (1), pp.9-42. ⟨10.1002/ejhf.654⟩. ⟨hal-01788726⟩